International Angiology最新文献

筛选
英文 中文
Five-factors Modified Frailty Index role as predictors of outcomes after proximal abdominal aortic aneurysms. 五因素改良脆弱指数作为近端腹主动脉瘤术后预后的预测因素。
IF 1.4 4区 医学
International Angiology Pub Date : 2023-12-01 Epub Date: 2023-11-09 DOI: 10.23736/S0392-9590.23.05071-X
Daniele Mascia, Annarita Santoro, Concetta Saracino, Andrea L Kahlberg, Roberto Chiesa, Germano Melissano
{"title":"Five-factors Modified Frailty Index role as predictors of outcomes after proximal abdominal aortic aneurysms.","authors":"Daniele Mascia, Annarita Santoro, Concetta Saracino, Andrea L Kahlberg, Roberto Chiesa, Germano Melissano","doi":"10.23736/S0392-9590.23.05071-X","DOIUrl":"10.23736/S0392-9590.23.05071-X","url":null,"abstract":"<p><strong>Background: </strong>The aim of the study was to evaluate the correlation between frailty, measured by the Five-Factor Modified Frailty Index (mFI-5) and mortality and all major adverse events (MAE) in patients who underwent proximal abdominal aortic aneurysm (p-AAA) open surgery (OS).</p><p><strong>Methods: </strong>Data of all elective patients submitted to p-AAA OS from 2010 to 2021 were recorded. Primary endpoints were 30-day mortality and mid-term survival and secondary endpoints included postoperative acute kidney injury (AKI), freedom from aortic reintervention and any MAE. The impact of frailty was assessed by univariate and multivariate analysis; mid-term overall survival were estimated using Kaplan-Meier method (log-rank test).</p><p><strong>Results: </strong>Two-hundred twenty-one patients (197 male, 24 female; aged 72.2±7.4) were included. Thirty-seven (16.4%) were octogenarians (>80 years). The mFI-5 was assessed in the entire group: mean mFI-5 was 0.29±0.12. One-hundred patients (100/221, 45.25%, 91:9 male-to-female ratio) were defined \"frail\" considering the mFI-5 cut-off >0.25. At univariate analysis a correlation was found between mFI-5>0.25 and mid-term mortality (Pearson correlation [r] 0.280, P<0.001) and AKI (r=0.146, P=0.030). No correlation with 30-day mortality was found (P not significant). At multivariate analysis mFI-5>0.25 increased the risk for midterm mortality (odds ratio 3.32, P=0.021) and postoperative AKI (OR 2.09, P<0.001). The effect of mFI-5>0.25 on mid-term mortality persisted after adjustment for age (P<0.001). Survival was estimated with Kaplan-Meyer method (mean follow-up of 52.7 months, 95% CI: 48.6-56.8); 68 (30.7%) deaths were recorded: 23 among non-frail patients (19.0%) and 45 among frail patients (45/100, 45%, P<0.001).</p><p><strong>Conclusions: </strong>These findings suggest that mFI-5 is a tool capable to identify \"frail\" patients, who appear to be at increased risk of postoperative AKI and mid-term mortality, but not 30-day mortality. Five-factor modified Frailty Index assessment is simple, fast and can be widely applied in surgical practice to perform appropriate risk stratifications.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"520-527"},"PeriodicalIF":1.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71521331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors and outcomes of deep venous thrombosis in patients with acute ischemic stroke: results from the Chinese Stroke Center Alliance. 急性缺血性卒中患者深静脉血栓形成的预测因素和预后:中国卒中中心联盟的研究结果。
IF 1.4 4区 医学
International Angiology Pub Date : 2023-12-01 Epub Date: 2024-01-16 DOI: 10.23736/S0392-9590.23.05077-0
Weixin Cai, Ran Zhang, Yongjun Wang, Zixiao Li, Liping Liu, Hongqiu Gu, Kaixuan Yang, Xin Yang, Chunjuan Wang, Anxin Wang, Weige Sun, Yunyun Xiong
{"title":"Predictors and outcomes of deep venous thrombosis in patients with acute ischemic stroke: results from the Chinese Stroke Center Alliance.","authors":"Weixin Cai, Ran Zhang, Yongjun Wang, Zixiao Li, Liping Liu, Hongqiu Gu, Kaixuan Yang, Xin Yang, Chunjuan Wang, Anxin Wang, Weige Sun, Yunyun Xiong","doi":"10.23736/S0392-9590.23.05077-0","DOIUrl":"10.23736/S0392-9590.23.05077-0","url":null,"abstract":"<p><strong>Background: </strong>No large-scale, multicenter studies have explored the incidence rate and predictors of deep vein thrombosis (DVT) in patients with acute ischemic stroke (AIS). We aimed to determine the risk factors of DVT, and assess the association between DVT and clinical outcomes in AIS patients.</p><p><strong>Methods: </strong>In total, 106,612 patients with AIS enrolled in the Chinese Stroke Center Alliance between August 2015 and July 2019 were included. The predictors of DVT in AIS patients were screened based on the logistic regression analysis for the comparison of the characteristics and clinical outcomes of patients with and without DVT.</p><p><strong>Results: </strong>The overall incidence of DVT after AIS was 4.7%. Factors associated with increased incidence of DVT included advanced age, female sex, high admission National Institutes of Health Stroke Scale score, history of cerebral hemorrhage, transient ischemic attack (TIA), dyslipidemia, atrial fibrillation, and peripheral vascular disease, International Normalized Ratio (INR) <0.8 or >1.5, and blood uric acid >420 μmol/L. Ambulation and early antithrombotic therapy were associated with a lower incidence of DVT. Patients with DVT was associated with longer hospital stay (OR=1.44, 95% CI: 1.35-1.54), and higher in-hospital mortality (OR=1.68, 95% CI: 1.25-2.27).</p><p><strong>Conclusions: </strong>This large-scale, multi-center study showed that the occurrence of DVT in AIS patients is associated with various modifiable and objective indicators, such as abnormal INR and uric acid >420 μmol/L. Ambulatory status and early antithrombotic therapy can reduce the occurrence of DVT in AIS patients. In AIS patients, DVT may prolong the hospital stay and increase the risk of in-hospital mortality. Future research should focus on the clinical implementation of existing evidence on DVT prevention in AIS patients.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"503-511"},"PeriodicalIF":1.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139472442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic literature review and expert meeting report on health-related quality of life in chronic venous disease. 慢性静脉疾病患者健康相关生活质量的系统文献综述及专家会议报告。
IF 1.5 4区 医学
International Angiology Pub Date : 2023-12-01 Epub Date: 2023-11-28 DOI: 10.23736/S0392-9590.23.05108-8
Jorge H Ulloa, Fedor Lurie, Fabricio R Santiago, Sergio Gianesini, Lourdes Reina, Jinsong Wang, Ravul Jindal, Wassila Taha, Mamuka Bokuchava, Armando Mansilha
{"title":"Systematic literature review and expert meeting report on health-related quality of life in chronic venous disease.","authors":"Jorge H Ulloa, Fedor Lurie, Fabricio R Santiago, Sergio Gianesini, Lourdes Reina, Jinsong Wang, Ravul Jindal, Wassila Taha, Mamuka Bokuchava, Armando Mansilha","doi":"10.23736/S0392-9590.23.05108-8","DOIUrl":"10.23736/S0392-9590.23.05108-8","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic venous disease (CVD) can lead to considerable morbidity and impact health-related quality of life (HRQoL). The aim of this review was twofold: (i) to provide a deeper understanding of how CVD affects HRQoL (physical, psychological and social functioning), and (ii) to review the impact of evidence-based veno-active drugs (VADs) on HRQoL.</p><p><strong>Evidence acquisition: </strong>For the effect of CVD on HRQoL, information was gathered during an Expert Consensus Meeting, during which data were presented from both the patient and physician perspective assessed with validated quality-of-life measures. For the impact of VADs on HRQoL, a systematic literature review was performed using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic databases were searched for real world evidence or randomized-controlled trials (RCT) vs. placebo, reporting data on the influence of VADs on HRQoL in patients with CVD.</p><p><strong>Evidence synthesis: </strong>CVD can negatively affect daily life in a number of areas related to pain, physical function and social activities. The impact of CVD on HRQoL begins early in the disease and for patients the emotional burden of the disease is as high as the physical burden. In contrast, physicians tend to overestimate the physical impact. The database search yielded 184 unique records, of which 19 studies reporting on VADs and HRQoL in patients with CVD met the inclusion criteria (13 observational and 6 RCTs). Micronized purified flavonoid fraction (MPFF) was the most represented agent, associated with 12/19 studies (2 RCTs and 10 observational). Of the 6 RCTs, only MPFF, aminaphthone and low-dose diosmin provided statistically significant evidence for improvement on HRQoL compared with placebo; for the other VADs improvements in HRQoL were not statistically different from placebo. MPFF was also associated with improvements in HRQoL in the observational studies, across all CEAP clinical classes, as monotherapy or in combination with other conservative therapy, and for all aspects of HRQoL: physical, psychological, and social. Real-world data for the other VADs were scarce. Ruscus extract, sulodexide and a semi-synthetic diosmin were each represented by a single observational study and these limited data were associated with statistically significant improvements compared with baseline in overall and subdomain scores across the range of CEAP clinical classes.</p><p><strong>Conclusions: </strong>CVD can impair patients' HRQoL significantly at all stages of the disease. MPFF has the greatest evidence base of clinical use in both RCT and real-world observational studies for effectiveness on HRQoL and is recognized by international guidelines. The complete video presentation of the work is available online at www.minervamedica.it (Supplementary Digital Material 1: Supplementary Video 1, 5 min, 194 MB).</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"465-476"},"PeriodicalIF":1.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138444586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circumferential degree of tibial artery calcification is associated with infrapopliteal endovascular revascularization outcomes in patients with chronic limb-threatening ischemia. 胫骨动脉钙化的周缘程度与慢性肢体缺血患者的胫骨下血管内血运重建结果有关。
IF 1.4 4区 医学
International Angiology Pub Date : 2023-12-01 Epub Date: 2023-12-11 DOI: 10.23736/S0392-9590.23.05130-1
Yue Dong, Yuankang Liu, Hongli Liao, Panpan Cheng, Xiaoqi Liu, Wei Huang, Shuang Cai, Cuiping Jiang, Shuhua Liu, Xiangyang Xu, Ying Li
{"title":"Circumferential degree of tibial artery calcification is associated with infrapopliteal endovascular revascularization outcomes in patients with chronic limb-threatening ischemia.","authors":"Yue Dong, Yuankang Liu, Hongli Liao, Panpan Cheng, Xiaoqi Liu, Wei Huang, Shuang Cai, Cuiping Jiang, Shuhua Liu, Xiangyang Xu, Ying Li","doi":"10.23736/S0392-9590.23.05130-1","DOIUrl":"10.23736/S0392-9590.23.05130-1","url":null,"abstract":"<p><strong>Background: </strong>Tibial artery calcification (TAC) is correlated with an increased risk of amputation and mortality in patients with chronic limb-threatening ischemia (CLTI). The association between calcification characteristics and adverse limb events of CLTI. However, it has not been assessed. This study aims to assess the relationship between the characteristics of TAC based on computed tomography angiography (CTA) scans and postoperative outcomes in patients with CLTI undergoing infrapopliteal endovascular therapy.</p><p><strong>Methods: </strong>This was a retrospective study of patients who underwent infrapopliteal endovascular revascularization for CLTI and had a preoperative CTA scan. Based on CTA, TAC was divided into the following categories: annularity, thickness, continuity and severity. Cox regression models using generalized estimating equations were performed to assess the relationship between calcification characteristics and postoperative outcomes. The outcomes evaluated were the occurrence of all cause mortality (ACM) and unplanned amputation.</p><p><strong>Results: </strong>Among the 148 patients undergoing endovascular, there were 50 (33.8%) patients died and 26 (17.6%) patients underwent unplanned amputation. Annular calcification was more common in the ACM group than in the non-ACM group. No significant differences were found between the two groups with regard to the probability of calcification in the thickness and the continuity (P>0.05). Patients in the unplanned amputation group had significantly annular, thin and continuity calcifications (P<0.05) than those in the non-unplanned amputation group. The presence of annular calcification was an independent predictor of ACM (hazard ratio (HR), 3.186; 95% confidence interval (CI), 1.781-5.702; P<0.001) and unplanned amputation (HR, 3.739; 95% CI, 1.707-8.191; P<0.05).</p><p><strong>Conclusions: </strong>Among patients with CLTI, the occurrence of annular calcification in the tibial artery are related to a greater chance of ACM and unplanned amputation in the postoperative period. The circumferential degree of TAC of the operated limb can be considered as a marker of clinical prognosis in this group of patients.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"528-536"},"PeriodicalIF":1.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138794290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The correlation between Caprini score and the risk of venous thromboembolism after varicose vein surgery. 卡普里尼评分与静脉曲张术后静脉血栓栓塞风险的相关性。
IF 1.4 4区 医学
International Angiology Pub Date : 2023-12-01 Epub Date: 2023-12-11 DOI: 10.23736/S0392-9590.23.05050-2
Kirill V Lobastov, Maria V Shaldina, Athena V Matveeva, Anna V Kovalchuk, Denis A Borsuk, Ilya V Schastlivtsev, Leonid A Labeko, Alexey A Fokin
{"title":"The correlation between Caprini score and the risk of venous thromboembolism after varicose vein surgery.","authors":"Kirill V Lobastov, Maria V Shaldina, Athena V Matveeva, Anna V Kovalchuk, Denis A Borsuk, Ilya V Schastlivtsev, Leonid A Labeko, Alexey A Fokin","doi":"10.23736/S0392-9590.23.05050-2","DOIUrl":"10.23736/S0392-9590.23.05050-2","url":null,"abstract":"<p><strong>Background: </strong>The study aims to identify the incidence of symptomatic and asymptomatic venous thromboembolism (VTE) after minimally invasive varicose vein surgery and to assess the predictability of the Caprini risk score (CRS).</p><p><strong>Methods: </strong>CAPrini Score In Venous Surgery (NCT03041805) is a registry-based prospective study that enrolls patients undergoing minimally invasive open (high ligation, stripping, miniphlebectomy) and endovascular (thermal and non-thermal ablation) surgery on varicose veins. The main inclusion criteria are CRS assessment before intervention and a duplex ultrasound scan performance within 2-4 weeks after surgery. The primary outcome is a combination of asymptomatic or symptomatic DVT, including EHIT of class 2-4 and PE.</p><p><strong>Results: </strong>Totally 1878 records with defined outcomes were analyzed. The mean age of patients was 46.9±13.3 years; 66% were female. Endovenous laser ablation was performed in 88%. Varicose tributaries were treated in 40%, perforating veins in 3.9% of cases. CRS ranged from 1 to 12 (mean of 4.0±1.5). Prophylactic anticoagulation was prescribed in 20%. The primary outcome was reported in 63 cases (3.4%; 95% CI, 2.7-4.3%), comprising asymptomatic (N.=29, 1.5%) or symptomatic (N.=10, 0.5%) DVT or EHIT (n=28, 1.6%). No PE was reported. A significant correlation was found between CRS and VTE incidence (P=0.001). Under logistic regression CRS (OR, 1.3; 95% CI, 1.1-1.6) along with treatment of tributaries (OR, 6.3; 95% CI, 3.0-13.0) and perforating veins (OR, 10.7; 95% CI, 3.8-30.2) were associated with VTE in the absence of prophylactic anticoagulation.</p><p><strong>Conclusions: </strong>The incidence of VTE after ablation of superficial veins is 3.4%, predominantly due to asymptomatic EHIT and DVT, and significantly correlates with CRS.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"477-487"},"PeriodicalIF":1.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138794291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abdominal aortic aneurysms volume growth patterns with three-dimensional ultrasound. 腹主动脉瘤体积增长模式的三维超声检查。
IF 1.4 4区 医学
International Angiology Pub Date : 2023-12-01 Epub Date: 2023-10-23 DOI: 10.23736/S0392-9590.23.05103-9
Ulver S Lorenzen, Qasam M Ghulam, Laurence Rouet, Nikolaj Eldrup, Timothy Resch, Jonas P Eiberg
{"title":"Abdominal aortic aneurysms volume growth patterns with three-dimensional ultrasound.","authors":"Ulver S Lorenzen, Qasam M Ghulam, Laurence Rouet, Nikolaj Eldrup, Timothy Resch, Jonas P Eiberg","doi":"10.23736/S0392-9590.23.05103-9","DOIUrl":"10.23736/S0392-9590.23.05103-9","url":null,"abstract":"<p><strong>Background: </strong>Three-dimensional ultrasound (3D-US) and computed tomography (CT) have proven abdominal aortic aneurysm (AAA) volume a more sensitive measure of growth than diameter. This proof-of-concept study aimed to investigate the clinical applicability of two-dimensional ultrasound and 3D-US for AAA diameter and volume growth pattern evaluation.</p><p><strong>Methods: </strong>AAA patients with at least three follow-ups within a minimum of 24 months were included prospectively and consecutively from the COpenhagen Aneurysms CoHort (COACH). Individual diameter and volume growth rates were categorized as rapid, slow, or no growth (>6.0, 3.8-6.0, and ≤3.7 mm/year for diameter. >17.4, 8.8-17.3, and ≤8.7 mL/year for volume). Similarly, diameter and volume growth patterns were categorized as as linear, exponential, staccato, and indeterminate growth, based from individual regressions.</p><p><strong>Results: </strong>Thirty patients were included, of which 19 (63%) had no diameter growth, 10 (33%) had slow growth, and one (3%) had rapid growth. Regarding volume, 11 (37%) patients had no growth, 12 (40%) had slow growth, and seven (23%) had rapid growth. Growth patterns according to diameter showed that 18 (60%) patients had linear growth, none had staccato or exponential growth. Twelve (40%) were indeterminate. Volume growth patterns found 19 (63%) patients with linear growth, 3 (10%) with staccato, and none with exponential growth. Eight (27%) were indeterminate.</p><p><strong>Conclusions: </strong>Analysis of AAA volume growth patterns is a practical and safe modality that seems more sensitive at detecting growth patterns than AAA diameter. Volume also detects more AAA growth than diameter.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"512-519"},"PeriodicalIF":1.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49690361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of long-pulsed 1064-nm Nd:YAG laser on telangiectasias and reticular veins: a human in-vivo histological study. 长脉冲1064 nm Nd:YAG激光对毛细血管扩张和网状静脉的影响:人体内组织学研究。
IF 1.4 4区 医学
International Angiology Pub Date : 2023-12-01 Epub Date: 2023-11-16 DOI: 10.23736/S0392-9590.23.05056-3
Rodrigo Kikuchi, Marcelo H Grill, Roberto A Caffaro, Maria A Silva, Samantha Neves, Ronie C Cardoso, Camilla M Ribeiro, Viviane S da Silva, Eduardo Ramacciotti
{"title":"Effects of long-pulsed 1064-nm Nd:YAG laser on telangiectasias and reticular veins: a human in-vivo histological study.","authors":"Rodrigo Kikuchi, Marcelo H Grill, Roberto A Caffaro, Maria A Silva, Samantha Neves, Ronie C Cardoso, Camilla M Ribeiro, Viviane S da Silva, Eduardo Ramacciotti","doi":"10.23736/S0392-9590.23.05056-3","DOIUrl":"10.23736/S0392-9590.23.05056-3","url":null,"abstract":"<p><strong>Background: </strong>Telangiectasias and reticular veins are associated with aesthetic disorders. Sclerotherapy is the gold standard treatment, but long-pulsed 1064-nm Nd:YAG laser (LP1064 laser) is also used. No data on the human histological effects of these lasers are reported. The objective was to test different LP1064 laser parameters and their histological effects on the dermis, collagen, telangiectasias, and reticular veins.</p><p><strong>Methods: </strong>This was a single-center, prospective, single-arm, case-control, human study. During surgery (dermolipectomy), the abdominal section of 10 female patients was irradiated with 6 different transdermal LP1064 laser parameters after anesthesia. Ten pieces with areas of varying irradiation were evaluated according to the characteristics of the vessels identified by area. In each piece, two irradiation areas were performed per group, totaling 12 irradiation areas per piece, with 120 regions later analyzed at the end of the ten samples. After removing the surgical product, histological sections were extracted, and the dermis, telangiectasias, and reticular veins were analyzed.</p><p><strong>Results: </strong>Histological analysis showed that exposition to six different parameters from LP1064 laser led to significant dermal layer separation and collagen alterations. The effects were inconsistent on the loss of endothelial cells, intravascular thrombus formation, and fusion of vascular walls for both telangiectasias and reticular veins. In reticular veins, effects on intravascular thrombus formation and vascular wall fusion were not observed.</p><p><strong>Conclusions: </strong>The LP1064 laser in monotherapy with fixed settings did not lead to a consistent vascular lesion to promote immediate occlusion in telangiectasias and reticular veins. This strategy may not work as monotherapy for small vein treatment, but the possible late response to the LP1064 laser cannot be ruled out and require further investigation.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"457-464"},"PeriodicalIF":1.4,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136397307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduction of lower-limb edema in patients with chronic venous disease by micronized purified flavonoid fraction: a systematic literature review and meta-analysis. 微粉化纯化类黄酮成分减轻慢性静脉疾病患者下肢水肿:系统性文献综述和荟萃分析。
IF 1.5 4区 医学
International Angiology Pub Date : 2023-12-01 Epub Date: 2023-12-22 DOI: 10.23736/S0392-9590.23.05084-8
Eberharde Rabe, Vanessa Blanc-Guillemaud, Marie-Blanche Onselaer, Yoann Blangero, Hurrem-Pelin Yaltirik, Andrew Nicolaides
{"title":"Reduction of lower-limb edema in patients with chronic venous disease by micronized purified flavonoid fraction: a systematic literature review and meta-analysis.","authors":"Eberharde Rabe, Vanessa Blanc-Guillemaud, Marie-Blanche Onselaer, Yoann Blangero, Hurrem-Pelin Yaltirik, Andrew Nicolaides","doi":"10.23736/S0392-9590.23.05084-8","DOIUrl":"10.23736/S0392-9590.23.05084-8","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The prevalence of lower limb edema is high among patients with chronic venous disease (CVD). Several clinical studies with various designs have assessed the effect of micronized purified flavonoid fraction (MPFF) on edema. The aim of this work was to provide a comprehensive and accurate evaluation of the reduction in ankle and calf circumference as an indicator of lower limb edema reduction in patients with CVD treated with MPFF by combining studies that use different designs in a single group meta-analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Evidence acquisition: &lt;/strong&gt;We conducted a systematic literature review in April 2022 based on the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) criteria to identify prospective studies investigating the effect of oral MPFF treatment 1000 mg/day on ankle and calf circumference in patients with CVD. Studies with population including at least one patient with an ulcer were excluded. All prospective studies irrespectively of design (i.e., interventional and non-interventional studies, randomized controlled trials (RCTs), non-randomized studies, studies without a control or reference treatment) were eligible. The Medline, Embase and Cochrane databases were searched. Endpoints were ankle and calf circumference measurements and their overall mean change from baseline estimated with random-effects meta-analysis methods. The evaluation criterion feeling of swelling was also analyzed as a standardized mean change (SMC) with 95% confidence intervals after combination of quantitative scales.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Evidence synthesis: &lt;/strong&gt;Among 861 articles identified, eight studies (five RCTs including one placebo-controlled, three non-comparative studies) met the criteria. The overall population consisted of 1635 patients, predominantly female (89% ranging from 64% to 94%) with a mean age of 47 years ranging from 41 to 48 years. Mean reduction in ankle circumference was 6.0 mm (95%CI: 3.6 to 8.4; P&lt;0.001) and 7.0 mm (95%CI: 0.9 to 13.1; P=0.024) after two and at least six months of treatment respectively. The results were similar when considering the study type RCTs and non-RCTs. Mean reduction in calf circumference was 5.7 mm (95%CI: 2.8 to 8.6; P&lt;0.001) and 6.7 mm (95%CI: 5.2 to 8.1; P&lt;0.001), at two months and at the last post-baseline evaluation respectively. Heterogeneity among studies was statistically significant (degree of consistency I&lt;sup&gt;2&lt;/sup&gt;=93.5%; P&lt;0.001 and I&lt;sup&gt;2&lt;/sup&gt;=81.1%, P&lt;0.01 for ankle and calf circumference, respectively). In the three studies reporting the effect on feeling of swelling a significant standardized mean change (SMC) reduction of 2.2 (95%CI: 0.2 to 4.2; P=0.028) on a quantitative scale was observed after two months of treatment with MPFF.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;MPFF appeared to be effective in reducing ankle and calf circumference as well as feeling of swelling irrespective of study design. The circumference reduction is p","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"488-502"},"PeriodicalIF":1.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138829574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5G-based robot-assisted remote ultrasound in vascular disease: a new era is coming! 基于 5G 的血管疾病机器人辅助远程超声:新时代即将到来!
IF 1.5 4区 医学
International Angiology Pub Date : 2023-12-01 Epub Date: 2023-12-11 DOI: 10.23736/S0392-9590.23.05138-6
Edoardo Cervi, Daniele Bissacco
{"title":"5G-based robot-assisted remote ultrasound in vascular disease: a new era is coming!","authors":"Edoardo Cervi, Daniele Bissacco","doi":"10.23736/S0392-9590.23.05138-6","DOIUrl":"10.23736/S0392-9590.23.05138-6","url":null,"abstract":"","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"537-538"},"PeriodicalIF":1.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138794289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TEVAR for aortic arch lesions combining physician-modified endograft and in-situ fenestration. 主动脉弓病变TEVAR联合医师改良的内移植物和原位开窗。
IF 1.4 4区 医学
International Angiology Pub Date : 2023-10-01 Epub Date: 2023-11-14 DOI: 10.23736/S0392-9590.23.05063-0
Yuxi Zhao, Zhaoxiang Zeng, Xianhao Bao, Mingwei Wu, Jiaxuan Feng, Zaiping Jing, Rui Feng
{"title":"TEVAR for aortic arch lesions combining physician-modified endograft and in-situ fenestration.","authors":"Yuxi Zhao, Zhaoxiang Zeng, Xianhao Bao, Mingwei Wu, Jiaxuan Feng, Zaiping Jing, Rui Feng","doi":"10.23736/S0392-9590.23.05063-0","DOIUrl":"10.23736/S0392-9590.23.05063-0","url":null,"abstract":"<p><strong>Background: </strong>The aim of this retrospective study was to investigate the outcomes of combining physician-modified endograft (PMEG) and in-situ fenestration (ISF) for aortic arch repair.</p><p><strong>Methods: </strong>A retrospective analysis was performed in 12 patients with aortic arch pathologies who underwent thoracic endovascular aortic repair with PMEG and ISF between June 2019 and February 2020.</p><p><strong>Results: </strong>Revascularizations of supra-aortic arteries were successfully performed in 91.7% patients (11/12). One patient with aberrant right subclavian artery was unsuccessful because of tortuosity and sharp angle. One patient received endovascular exclusion by Viabahn due to artery injury of the femoral access. During the follow-up (mean 22.7 months), one patient underwent Bentall surgery because of retrograde type A aortic dissection, and one patient received coils embolization due to occurrence of a type I endoleak. In addition, one patient died of myocardial infarction 13 months after surgery. Results obtained after computed tomography angiography confirmed patency of all the supra-aortic arteries.</p><p><strong>Conclusions: </strong>Combining PMEG and ISF could be a feasible option for aortic arch lesions in selected patients. Long-term durability concerns require further evaluation.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"412-419"},"PeriodicalIF":1.4,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92153678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信